FDA Asks Healthcare Professionals to Weigh the Benefits and Risks of Topamax, Reports The CJF
FDA Asks Healthcare Professionals to Weigh the Benefits and Risks of Topamax, Reports The CJF The FDA recently released a safety announcement urging healthcare professionals to consider all benefits and risks involved in Topamax treatment before prescribing the antiepileptic drug to women of childbearing age. According to the FDA, Topamax use during pregnancy may be linked to an increased risk of birth defects among exposed infants, particularly cleft lip and cleft palate. For more information about Topamax FDA warnings and the pregnancy risks of the antiepileptic Topamax, visit http://www.
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Categories
- Articles 308
- Bankruptcy 44
- Business 133
- Cases & Codes 68
- Contracts 27
- Criminal Law 122
- Employment 24
- Expert Reports 3
- Expert Witness 34
- Family Law 57
- Form Letters 15
- Immigration 3
- Intellectual Prop 32
- Internet Law 10
- Law Practice 99
- Law School 2
- Legal Research 19
- Litigation 186
- Miscellaneous 64
- PR Web 41689
- Personal Injury 608
- Press Release 43
- Probate 54
- Real Estate 68
- Tax Law 23
- Workers Comp 4